1. Home
  2. GNPX vs SQFT Comparison

GNPX vs SQFT Comparison

Compare GNPX & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

N/A

Current Price

$2.63

Market Cap

2.2M

Sector

Health Care

ML Signal

N/A

Logo Presidio Property Trust Inc.

SQFT

Presidio Property Trust Inc.

N/A

Current Price

$1.21

Market Cap

1.9M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
GNPX
SQFT
Founded
2009
1999
Country
United States
United States
Employees
13
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
1.9M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
GNPX
SQFT
Price
$2.63
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 160.2K
76.7K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $16,814,708.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.17
$1.14
52 Week High
$12.97
$6.40

Technical Indicators

Market Signals
Indicator
GNPX
SQFT
Relative Strength Index (RSI) 33.70 38.62
Support Level $1.88 $1.17
Resistance Level $3.11 $2.37
Average True Range (ATR) 0.29 0.11
MACD -0.04 0.02
Stochastic Oscillator 11.33 22.50

Price Performance

Historical Comparison
GNPX
SQFT

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: